Updated Monday, 12/14. Six IPOs and five SPACs are scheduled to raise $2.8 billion in the week ahead as the IPO market starts to slow down before the holidays. Bargain e-commerce platform Wish (WISH) plans to raise $1.1...read more
Updated Monday, 7/13. Nine IPOs and one SPAC plan to raise $1.5 billion in the week ahead, led by health insurance marketplace GoHealth (GOCO). More deals could join the IPO calendar in the week ahead, including Apple workflow...read more
Five IPOs and one SPAC went public this past week led by Royalty Pharma (RPRX), which completed the largest US IPO of 2020 to date. Healthcare continued to dominate, with all five IPOs coming from the sector. Royalty Pharma (RPRX)...read more
Progenity, which sells in vitro molecular tests for prenatal and disease screening, raised $100 million by offering 6.7 million shares at $15, within the range of $14 to $16. Progenity plans to list on the Nasdaq under the symbol PROG. Piper Sandler, Wells...read more
US IPO Week Ahead: The IPO market makes a holiday WISH in a 6 IPO week
Updated Monday, 12/14. Six IPOs and five SPACs are scheduled to raise $2.8 billion in the week ahead as the IPO market starts to slow down before the holidays. Bargain e-commerce platform Wish (WISH) plans to raise $1.1...read more
US IPO Week Ahead: GoHealth takes the lead in a 9 IPO Week
Updated Monday, 7/13. Nine IPOs and one SPAC plan to raise $1.5 billion in the week ahead, led by health insurance marketplace GoHealth (GOCO). More deals could join the IPO calendar in the week ahead, including Apple workflow...read more
US IPO Weekly Recap: Royalty Pharma takes the crown in 5 IPO week
Five IPOs and one SPAC went public this past week led by Royalty Pharma (RPRX), which completed the largest US IPO of 2020 to date. Healthcare continued to dominate, with all five IPOs coming from the sector. Royalty Pharma (RPRX)...read more
Progenity prices IPO at $15 midpoint
Progenity, which sells in vitro molecular tests for prenatal and disease screening, raised $100 million by offering 6.7 million shares at $15, within the range of $14 to $16. Progenity plans to list on the Nasdaq under the symbol PROG. Piper Sandler, Wells...read more